Chargement en cours...
Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist
CpG DNA, a ligand for Toll-like receptor 9 (TLR9), has been one of the most promising immunotherapeutic agents. Although there are several types of potent humanized CpG oligodeoxynucleotide (ODN), developing “all-in-one” CpG ODNs activating both B cells and plasmacytoid dendritic cells forming a sta...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
National Academy of Sciences
2014
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3939924/ https://ncbi.nlm.nih.gov/pubmed/24516163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1319268111 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|